ARTICLE | Clinical News
IV Genasense oblimersen regulatory update
June 25, 2007 7:00 AM UTC
GNTA plans to submit a request to FDA's Center for Drug Evaluation and Research (CDER) within the next 4 weeks for a review of the agency's decision not to overturn a not approvable letter for the NDA...